The Wall Street Transcript
The Wall Street Transcript - In-Depth Interviews for Investors
Healthcare >> CEO Interviews >> September 11, 2014

Interview with the CFO: Cleveland BioLabs, Inc. (CBLI)

Lyons, Neil
Neil Lyons joined Cleveland BioLabs, Inc., as Chief Financial Officer in 2011. He has more than 30 years of experience in operations, finance, strategy, SEC compliance, information systems and corporate governance in both public and private companies. Prior to joining the company, Mr. Lyons served as Chief Financial Officer, Secretary and Treasurer of RegeneRx Biopharmaceuticals, Inc., where he led several financial transactions, influenced clinical/corporate strategy, identified and captured government grant opportunities, directed investor relations, developed financial models, and implemented investment strategies and employee benefit programs. From 2003 until 2005, Mr. Lyons founded and was the Principal of Ironbridge Consulting, a firm providing financial management advisory services, including the implementation of Sarbanes-Oxley Act compliance procedures, to businesses in the Washington, D.C., metro area. From 1998 until 2003, he was the Vice President, Finance of SkyBridge Limited Partnership, an international satellite broadband startup affiliated with Alcatel, where he secured significant amounts of capital, and was an active participant in acquisition and joint venture activities. Prior to that, he served in various positions at Bell Atlantic — now Verizon — and HFS, Inc., a major Department of Defense contractor. Mr. Lyons started his career practicing public accounting with Deloitte and Arthur Young. Mr. Lyons is a certified public accountant and received a Bachelor of Science degree in accounting, magna cum laude, from Florida Southern College. Profile
TWST: Can you provide an overview of the company and describe your core technology?

Mr. Lyons: Certainly. Our key focus is oncology, but we also have a pivotal-stage radiation

Top Company Interviews

Microsoft Corporation
Intel Corporation
Pfizer, Inc.
General Electric Company
Walmart Inc.
International Business Machines Corporation
Citigroup Inc.
Exxon Mobil Corporation
Bank of America Corporation
Dell Inc.
Verizon Communications Inc.
Alphabet Inc

Register for a Free Account to gain greater access to The Wall Street Transcript right now

CEO INTERVIEWS
Interview with the President and CEO: PDS Biotechnology Corporation (NASDAQ:PDSB)
Interview with the Founder and Executive Chairman: Organovo Holdings Inc. (NASDAQ:ONVO)
Interview with the Co-Founder and CEO: Equillium Inc. (NASDAQ:EQ)
SECTOR ROUNDTABLES
Natural Gas Weighs Heavy On E&P Near-Term Prospects
Roundtable Forum:optimism Despite Uncertainty In For-profit Education
Roundtable Forum:a Shift In Focus To Natural Gas From Oil
MONEY MANAGER INTERVIEWS
Electric Cars and AI Fuel Long-Term Electricity Demand
Separating the Real Winners and Losers in the AI Boom
Generating Dividend Yield That’s Not Correlated to Interest Rates
ANALYST INTERVIEWS
Robust M&A Activity Provides Tailwind to Biotech Sector
Seeking Out Game Changers in Re-Emerging Biotech Sector
Obesity Drugmakers Still a ‘Buy’ Despite Lofty Valuations
Since 1963
© The Wall Street Transcript 2016, 2024
Terms and Conditions
Privacy Policy